Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia
Open Access
- 31 January 2011
- journal article
- research article
- Published by Wiley in Genes, Brain and Behavior
- Vol. 10 (4) , 410-417
Abstract
Neurocognitive dysfunction is a core feature of schizophrenia with particularly prominent deficits in verbal episodic memory. The molecular basis of this memory impairment is poorly understood and its relatedness to normal variation in memory performance is unclear. In this study, we explore, in a sample of cognitively impaired schizophrenia patients, the role of polymorphisms in seven genes recently reported to modulate episodic memory in normal subjects. Three polymorphisms (GRIN2B rs220599, GRM3 rs2189814 and PRKCA rs8074995) were associated with episodic verbal memory in both control and patients with cognitive deficit, but not in cognitively spared patients or the pooled schizophrenia sample. GRM3 and PRKCA acted in opposite directions in patients compared to controls, possibly reflecting an abnormal brain milieu and/or adverse environmental effects in schizophrenia. The encoded proteins balance glutamate signalling vs. excitotoxicity in complex interactions involving the excitatory amino acid transporter 2 (EAAT2), implicated in the dysfunctional glutamatergic signalling in schizophrenia. Double carrier status of the GRM3 and PRKCA minor alleles was associated with lower memory test scores and with increased risk of schizophrenia. Single nucleotide polymorphism (SNP) rs8074995 lies within the PRKCA region spanned by a rare haplotype associated with schizophrenia in a recent UK study and provides further evidence of PRKCA contribution to memory impairment and susceptibility to schizophrenia. Our study supports the utility of parsing the broad phenotype of schizophrenia into component cognitive endophenotypes that reduce heterogeneity and enable the capture of potentially important genetic associations.Keywords
This publication has 56 references indexed in Scilit:
- Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alphaMolecular Psychiatry, 2009
- SimHap GUI: An intuitive graphical user interface for genetic association analysisBMC Bioinformatics, 2008
- Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout miceSynapse, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- No Gene Is an Island: The Flip-Flop PhenomenonThe American Journal of Human Genetics, 2007
- Transporters forL‐glutamate: An update on their molecular pharmacology and pathological involvementBritish Journal of Pharmacology, 2007
- The Consortium on the Genetics of Schizophrenia: Neurocognitive EndophenotypesSchizophrenia Bulletin, 2006
- Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte culturesGlia, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 2004